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We report a method for in vitro selection of cat-
alytically active enzymes from large libraries of
variants displayed on the surface of the yeast
S. cerevisiae. Two libraries, each containing
2 3 106 variants of horseradish peroxidase
(HRP), were constructed; one involved error-
prone PCR that sampled mutations throughout
the coding sequence, whereas the other in-
volved complete combinatorial enumeration of
five positions near the active site to non-cyste-
ine residues. The enzyme variants displayed on
the yeast surface were allowed to modify it with
a fluorescently labeled substrate. A combina-
tion of positive and negative selection applied
to the active-site-directed library resulted in
variants with up to an 8-fold altered enantiose-
lectivity, including its reversal, toward L/D-tyro-
sinol. In contrast, the library constructed by
using error-prone PCR yielded no HRP variants
with a significantly improved enantioselectivity.
INTRODUCTION
Enzymesare attractive catalysts for applications in organic
chemistry, primarily due to their exquisite stereospecific-
ity, and especially the ability to recognize and produce
particular enantiomers of chiral molecules [1]. Because
only a small fraction of reactions of interest to synthetic
chemists are catalyzed by naturally evolved enzymes, re-
cent years have seen a major effort to create enzymes
with altered activity, usually by reengineering existing en-
zymes. Directed evolution has proven to be a particularly
powerful approach to engineering enzymes [2, 3], as well
as other proteins [4], with improved properties, because
it does not require a detailed knowledge of protein struc-
ture and function. Instead, large libraries of proteins with1176 Chemistry & Biology 14, 1176–1185, October 2007 ª2007varying sequence, structure, and function are created,
followed by screening or selecting for variantswith desired
properties.
Themajor challenge in thedirectedevolutionof enzymes
is the creation of a stable linkage between genotype (the
DNA encoding a particular enzyme variant) and phenotype
(enzymatic activity). The most direct approach, which
separates different enzyme variants in wells of microtiter
plates, can be applied to almost any enzyme, but it limits
the throughput of screening to 103–104 variants per library
[5]. The alternative, in vitro selection by using display tech-
nologies, can process libraries of 106–1010 variants, but it
limits the types of enzymes and chemical reactions that
can be explored [6]. An indirect approach to in vitro selec-
tion for enzymatic activity uses binding to transition-state
analogs as an indication of potential activity [7]. Selection
methods that test the performance of variants in actual en-
zymatic reactions generally require that the reaction prod-
uct be trapped on the surface of a phage or bacterial cell
or insidebacterial cells. Alternatively,water-in-oil emulsion
droplets have been used to colocalize reaction products
with the bacteria that produce each enzyme variant [8].
To date, all selection methods applied to enzymes that
modify small molecules rely on bacterial or in vitro expres-
sionof enzymevariants, thusprecludingdirected evolution
of numerous eukaryotic enzymes with extensive disulfide
bonding or posttranslational modification. Whereas the
advantages of a selection system based on a eukaryotic
organism for the evolution of such enzymes are clear, the
onlyexampleof selection for enzymatic activity in aeukary-
ote described so far involves a negative selection of hom-
ing endonucleases unable to cleave their DNA targets in
yeast [9]. We set out to extend this work by designing a
yeast-based selection system that can be applied to en-
zymes not involved in the biology of the yeast cell.
We report a new, to our knowledge, method for in vitro
selection of enzymatic activity from large libraries of vari-
ants displayedon the surface of the yeastS. cerevisiae and
separated by fluorescence-activated cell sorting (FACS).
As previously demonstrated for antibody fragmentsElsevier Ltd All rights reserved
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Yeast-Display Selection for HRP Enantioselectivity[10, 11], extracellular receptor domains [12, 13], and a
eukaryotic lipase in a high-throughput screen [14], yeast
surface display is well suited to eukaryotic proteins. We
used the model enzyme horseradish peroxidase (HRP),
which contains four disulfide bonds, as well as a heme
prosthetic group, and cannot be expressed in a soluble
form in bacteria [15].
Due to the possibility of their applications to chemical
synthesis, HRP and other peroxidases have been sub-
jected to directed evolution by using random or directed
mutagenesis, DNA shuffling, and high-throughput screen-
ing to identify mutants with higher stability [16, 17] or al-
tered specificity [18]. In addition, a bacterial catalase has
been mutated and screened [19], and a catalytic antibody
raised against a transition-state analog has been mutated
and selected by phage display [20] for increased peroxi-
dase activity.
We focused on the enantioselectivity of HRP during its
catalysis of radical dimerization of two chiral phenolic sub-
strates—tyrosinol supplied in solution and tyrosine found
naturally on the yeast surface. Wild-type HRP shows a
marginal preference for L-tyrosinol over D-tyrosinol. Using
two separate selection strategies,weboth augmented and
reversed HRP enantioselectivity.
Enzymes with altered enantioselectivity have been engi-
neered previously [21, 22] by screening libraries random-
ized by error-prone PCR [23], mutagenesis of specific
active-site residues [24–27], or a combination of randomi-
zation methods [28–30] and DNA shuffling [31–33]. Se-
lected enantioselective variants contained between 1 and
11 mutations per gene; there were critical mutations found
in, ornear, theactivesite, aswell asat adistance from it [34].
To identify the most efficient randomization strategy to
manipulate enantioselectivity of HRP, we started our se-
lections with two different HRP-derived libraries. The first
one was constructed by using error-prone PCR and intro-
duced a range of mutations throughout the HRP gene. The
second library focused on 5 residues at, or close to, the
HRP active site and was designed to sample all possible
sequence permutations at those five positions. We found
that in selections for selectivity for D- and for L-tyrosinol,
only the active-site-directed library yielded variants with
a significantly enhanced enantioselectivity. While it is
tempting to conclude that the failure of the error-prone
PCR-generated library to yield variants with improved
enantioselectivity is due to the requirement for simulta-
neous mutation of multiple residues close to the active
site, which would be a rare event in the error-prone PCR
library, other possibilities exist; for instance, uneven or
insufficient coverage of the error-prone PCR library, or
selectivity and detection issues in the screen could also
account for the current results.
RESULTS AND DISCUSSION
Yeast Surface Display of Wild-Type
Horseradish Peroxidase
To demonstrate that HRP displayed on the yeast surface
retains enzymatic activity, the synthetic gene encodingChemistry & Biology 14, 1176–1the wild-type enzyme (Figure 1) was cloned into a pCT-de-
rived yeast surface display vector, pCT2, downstream
from the gene for Aga2 protein and upstream from a
c-myc tag (Figure 2A) and transformed into S. cerevisiae.
The presence of HRP on the yeast surfacewas established
by fluorescently labeling the cells with antibody against
C-myc, by using Alexa 633 dye. The enzymatic activity of
surface-displayed HRP was confirmed by incubating the
yeast cells with two substrates, hydrogen peroxide and ty-
rosinol labeled with a second fluorescent dye, Alexa 488
(Figure 2B). The resulting labeled yeast cells were charac-
terized by using analytical flow cytometry (Figure 2C). The
presence of double-labeled cells in the yeast transformed
with wild-type HRP, but not in the negative-control yeast
transformedwith the same plasmidmissing theHRPgene,
demonstrates that the yeast displaying HRP can incorpo-
rate the substrate, presumably by the reaction between
enzymatically produced, fluorescently labeled tyrosinol-
free radicals and tyrosines on the surface of membrane-
associated yeast proteins.
This approach to detecting HRP activity, first proposed
conceptually as ‘‘enzyme screening by covalent attach-
ment of products via enzyme display’’ by Becker and
Kolmar [6], is similar to the method used by Yin et al. [20],
who detected HRP-catalyzed modification of a phage-
displayed antibody fragment with biotinylated tyramine.
Whereasboth selections rely on the incorporation of a phe-
nolic substrate into protein associated with a display parti-
cle, by using a similar chemical reaction, the two ap-
proaches differ in two significant ways. First, our use of a
eukaryotic display organism allowed us to study HRP,
which cannot be expressed in an active form in bacteria
used to express protein in phage display. Second, our
use of tyrosinol, a chiral substrate, allows us to study enan-
tioselectivity of HRP.
As shown in Figure 2CandTable 1, Alexa 488-L-tyrosinol
appears to be incorporated into yeast only slightly more
efficiently than Alexa 488-D-tyrosinol, with the enantiose-
lectivity EL/D of 1.2.
The fact that the subpopulation of yeast transformed
with wild-type HRP with a low Alexa 633 signal, and thus
presumably a low level of HRP expression [35, 36], is still
labeled with Alexa 488-tyrosinol (Figure 2C) suggests
trans-labeling, i.e., that HRP displayed on a yeast cell at-
taches Alexa 488-labeled substrate onto a different yeast
cell. A significant amount of trans-labeling would disturb
the linkage between genotype and phenotype and thus
preclude selection for HRP enantioselectivity. We quanti-
fied the amount of trans-labeling by labeling a mixture of
a yeast strain displaying HRP and a C-terminal C-myc
tag and a yeast strain displaying bovine trypsin inhibitor I
(BPTI) and a C-terminal Flag tag. Most of the cells (62%)
expressing the C-myc tag (and HRP), but only 7% of the
cells expressing the Flag tag (and BPTI), were labeled
with Alexa 488. In addition, as shown in Figure 2C, yeast
transformed with wild-type HRPwith a high Alexa 633 sig-
nal, and thus a high level of HRP expression, incorporates
more Alexa 488-tyrosinol than the yeast with low-level ex-
pression of HRP; the amount of Alexa 488 incorporated is185, October 2007 ª2007 Elsevier Ltd All rights reserved 1177
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(A) Crystal structure (PDB ID: 1HCH). The HRPmain chain and the side chains of disulfide-bonded cysteines are shown in black. Residues 68, 69, 72,
73, and 74, which were randomized to make library HRP-C, are shown in red; the heme prosthetic group is shown in green; and the two calcium ions
are shown in blue.
(B) Wild-type protein sequence and DNA sequence used to construct HRP libraries. Unique restriction-enzyme recognition sites used in HRP cloning
and library construction are underlined. The wild-type protein sequence is shown in capital letters. Residues 68, 69, 72, 73, and 74, which were
randomized to make library HRP-C, are shown in red.roughly proportional to the level of expression. The combi-
nation of a low number of trans-labeled cells and the high
efficiency of cis-labeling by HRP-expressing cells pro-
vides a high enough cis-to-trans (i.e., signal-to-noise) ratio
to select newHRP variants based on enzymatic activity by
using yeast surface display.
Construction of HRP-Based Libraries
Weused two different HRP-based libraries to compare the
effectiveness of two common approaches to generating
sequence variation in libraries for in vitro evolution—ran-
dom versus active-site-directed mutagenesis.
The randomly mutagenized library, HRP-E, was gener-
ated by error-prone PCR amplification of the entire HRP
gene. Mutations could occur anywhere in the gene; be-
tween 0 and 17 DNA mutations per clone were observed
in the sequences of 24 randomly chosen clones from the
unscreened library, with a median of 3. The perceived ad-
vantage of this approach is that it samples all possible
types of mutations, namely, (i) single, double, and multiple
mutations; (ii) those in the active site and distal from it; and
(iii) those both affecting substrate binding and catalysis di-
rectly and through subtle changes in enzyme structure.
The disadvantage of this approach is that any physical
library generated by random mutagenesis is only a small
subset of all possible libraries generated by this method,
because it is impossible to sample all possible permuta-
tions of multiple mutations for all but the shortest1178 Chemistry & Biology 14, 1176–1185, October 2007 ª2007sequences. Library HRP-E contains 1.6 3 106 different
HRP variants.
The active-site-directed library, HRP-C, was generated
by exhaustive randomization of five positions at or near the
active site: Phe68, Gly69, Asn72, Ser73, and Ala74 (Fig-
ure 1), allowing any of the 19 non-Cys amino acid residues
to occur at each of the 5 positions. (Cysteine was ex-
cluded to avoid possible disruption of folding, dimeriza-
tion, or aggregation of HRP through unpaired cysteines
under the oxidizing conditions found in the yeast secre-
tory apparatus and outside the cell.) The limited number
of residues randomized allows an exhaustive sampling
of the 2.5 3 106 possible sequence permutations. The
proximity of the randomized sites to the active site
(Figure 1A) ensures that many of the mutations will have
a significant effect on enzyme activity; however, it leads
to the risk that the mutations may be too drastic to pre-
serve activity.
To compare the effectiveness of the two strategies for
library construction, we performed in vitro selections for
substrate enantioselectivity of HRP by using libraries
HRP-E and HRP-C in parallel, under the same conditions
and selection pressure, and then analyzed the most suc-
cessful clones selected from each library.
Selection of Enantioselective HRP Variants
Each library underwent two parallel selections by FACS,
one for enantioselectivity for D-tyrosinol over L-tyrosinolElsevier Ltd All rights reserved
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(A) The HRP gene fused to Aga2 and the c-myc tag is secreted from yeast and captured on the outside surface of the yeast cell through Aga1p–Aga2p
disulfide bonding. Antibodies against the c-myc tag are used to label those yeast cells that display HRP on their surfaces with Alexa 633 (blue star).
Active HRP attaches the substrate labeled with Alexa 488 (purple star) to an acceptor substrate (tyrosine) on the yeast surface.
(B) HRP-catalyzed radical polymerization of tyrosine and Alexa 488-tyrosinol.
(C) Analytical flow cytometry of yeast displaying negative-control yeast with no HRP gene and wild-type HRP by using Alexa 488-D- and L-tyrosinol.(ED/L), and one for L-tyrosinol over D-tyrosinol (EL/D), with al-
ternating rounds of positive and negative selection. For
example, the selection for ED/L alternated between FACS
of populations with the highest incorporation of Alexa
488-labeled D-tyrosinol (selection rounds 1, 3, 5, and 7;
Figure 3A) and FACS of populations with low incorporation
of Alexa 488-labeled L-tyrosinol (selection rounds 2, 4, 6,
and 8; Figure 3B).
Between 21 and 24 clones from each selected popula-
tion were sequenced, enantioselectivity of all of the clones
that appeared in the selected population more than once
was determined (Figure 4 and Tables 1 and 2).
Each selection from the active-site-directed library,
HRP-C (Table 1), yielded a single HRP variant that was
enriched more than any other selected clone, and whose
enantioselectivity exceeded that of all other clones in the
selected population and that of wild-type HRP. Variant
CD8.02, whose sequence was found in 76% of the clones
in the final population selected for ED/L, has a 3.4-fold pref-Chemistry & Biology 14, 1176–1erence for D- over L-tyrosinol, i.e., a 3.8-fold improvement
over wild-type HRP. Similarly, clone CL8.01, whose se-
quence was found in 52% of the clones in the final popu-
lation selected for EL/D, has a 9-fold preference for L- over
D-tyrosinol, which is a 7.5-fold improvement over wild-
type HRP.
In contrast, themost highly represented clones selected
from the randomly mutagenized library, HRP-E (Table 2),
for ED/L, were ED8.05 and ED8.02, which represented 19%
and 14%, respectively, of selected clones; their enantio-
selectivity was indistinguishable from that of the wild-
type HRP. Similarly, the selection from library HRP-E for
EL/D produced no HRP variants with a higher enantioselec-
tivity than the wild-type HRP; the sequence of wild-type
HRP was found in 74% of the sequenced clones from
that selected population.
In summary (Figure 5), selection from the active-site-
directed library yielded variants with both a higher ED/L and
EL/D, but selections from the error-prone PCR-generated185, October 2007 ª2007 Elsevier Ltd All rights reserved 1179
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change in enantioselectivity.
Mutational Analysis of Enantioselective
Variant CD8.02
The enantioselectivities of CD8.02-based mutants, in
which one of the four mutations at a time was reverted
back to the wild-type sequence, are shown in Table 3.
Table 1. HRP Variants from an Active-Site-Directed
Library Selected for Enantioselectivity for D- or
L-Tyrosinol
Selection for Enantioselectivity for D- over L-Tyrosinol
Clone Sequence Freq. ED/L
WT HRP FGNANSA 0.9 ± 0.1
CD8.02 EP..KA. 76% 3.4 ± 0.2
CD8.14 RP..HWT 10% 0.6 ± 0.1
CD8.01 WV..FWS 5% NA
CD8.07 MV..PMG 5% NA
CD8.11 HS..GM. 5% NA
Selection for Enantioselectivity for L- over D-Tyrosinol
Clone Sequence Freq. EL/D
WT HRP FGNANSA 1.2 ± 0.1
CL8.01 LA..ELY 52% 9 ± 2
CL8.09 WA..AM. 17% 1.9 ± 0.1
CL8.02 .A..VVT 13% 3.3 ± 0.7
CL8.03 HA..ARD 13% 1.4 ± 0.1
CL8.16 RH..WTT 4% NA
HRP variants from the active-site-directed library, HRP-C,
were selected for enantioselectivity for D-tyrosinol (ED/L) or
L-tyrosinol (EL/D). The sequence in the randomized region
(68–74) is shown, and the residues randomized to generate
library HRP-C are underlined. NA, not active (less than 10%
of wild-type HRP activity). Errors were derived from two inde-
pendent experiments.Two of the mutants, Rev69 (CD8.02(P69G)) and Rev72
(CD8.02(K72N)), lost activity against both L- andD-tyrosinol
to the degree that precluded accurate determination of
their enantioselectivities.MutantRev68 (CD8.02(E68F)) re-
mained sufficiently active, but its ED/L was half that of
CD8.02 (1.7 compared to 3.4). In contrast, mutant Rev73
(CD8.02(A73S)) had an even higher enantioselectivity
than its parent clone, ED/L = 5.5, which corresponds to
a 6-fold improvement over wild-type HRP.
That a single mutation from the selected CD8.02 se-
quence back to the wild-type at position 68, 69, or 72
abolishes activity or reduces enantioselectivity suggests
that, in the context of the selected CD8.02 sequence (in-
cluding Ala73), Glu68, Pro69, and Lys72 are all required
for catalytic activity and high ED/L. Such a requirement for
three non-wild-type residues is one possible explanation
for the failure of the error-prone PCR-generated library in
this selection, but others exist as well. Whereas error-
prone PCR is relatively efficient at sampling single and
double mutations throughout the HRP gene, the odds of
generating a particular combination of three mutations at
specific sites are low. In contrast, our active-site-directed
library, HRP-C, focused attention on and essentially enu-
merated all combinations of mutations at positions 68, 69,
72, 73, and 74. This complementary strategy enabled the
discovery of the highly enantioselective mutant CD8.02,
which requires three simultaneous changes from the
wild-type sequence for its favorable phenotype. It is not
possible to generalize to other cases from this one exam-
ple, but the relative effectiveness of whole-gene error-
prone methods that provide excellent coverage of single
and probably double mutants versus focused enumera-
tion methods of all multiple mutants at a small number of
sites remains an open research question. Other strategies
not employed here are also possible. The efficiency of
constructing multiple mutations nearby in three-dimen-
sional space by using a focused procedure might be par-
ticularly useful near the enzyme active and binding sites,
where there may be a high level of cooperativity. For iden-
tifying more distributed and less cooperative mutations,
approaches similar to the error-prone library utilized hereFigure 3. Selection for HRP Enantiose-
lectivity
(A and B) Populations shown were selected
from the active-site-directed library, HPR-C,
for enantioselectivity for D- over L-tyrosinol
(ED/L). (A) Positive selection in round 5. The
0.5% of HRP-expressing cells with the highest
Alexa 488-D-tyrosinol signal was collected. (B)
Negative selection in round 6. The 90% of
HRP-expressing cells with the lowest Alexa
488-L-tyrosinol signal was collected.
1180 Chemistry & Biology 14, 1176–1185, October 2007 ª2007 Elsevier Ltd All rights reserved
Chemistry & Biology
Yeast-Display Selection for HRP EnantioselectivityFigure 4. Determination of Enantiose-
lectivity
(A–D) Enantioselectivity of wild-type HRP, as
well as those of the most enantioselective se-
lected clones and the most enantioselective
site-directed mutant, determined by compari-
son of the enzymatic initial rates by using Alexa
488-D- versus L-tyrosinol. (A) Wild-type HRP,
(B) CL8.01, (C) CD8.02, (D) Rev73. Bullets,
solid line, incorporation of Alexa 488-D-tyrosi-
nol; triangles, dashed line, incorporation of
Alexa 488-L-tyrosinol; MFU, mean fluores-
cence units.might have an advantage, particularly if single and double
mutants can be combined to produce further enhance-
ments.
In principle, mutant Rev73, which had a higher enantio-
selectivity than CD8.02, should have been encoded in the
HRP-C library and selected in the selection for ED/L. Two
possible explanations for not selecting Rev73 from the
library are that a 5-fold oversampling of the theoretical
sequence space in the physical library was not sufficient
to include a copy of each possible sequence, and that
Rev73 had other properties that were selected against,
such as a lower expression level in yeast. Nevertheless,
we expect that thoroughly sampled active-site-directed
libraries should provide an advantage in in vitro evolution
of activity for enzymes whose structure and location of the
active site are known. This hypothesis is supported by
other enzyme-directed evolution studies [37].
Further Directions for Yeast-Based In Vitro
Evolution of Enzyme Activity
The use of FACS to capture variants of interest requires
physical association of product with the yeast cell that
harbors the gene for the enzyme variant. In this study,
we ensured this genotype-phenotype linkage by utilizing
as one of the substrates Tyr residues that are ubiquitous
on the surface of yeast. However, the use of yeast surface
display is not limited to the study of enzymes whose sub-
strates are natural components of the yeast cell wall. WeChemistry & Biology 14, 1176–1propose that this method can be applied to other bimolec-
ular reactions by tethering one of the synthetic substrates
to the surface of yeast (analogously to the tyrosine natu-
rally present on the yeast cell wall in the HRP example),
and by adding the second substrate in solution (like tyro-
sinol in the HRP example). A generalizable method for
covalently attaching a small molecule to the yeast surface
was recently demonstrated for biotin, which was attached
to the yeast surface through a PEG linker with an NHS
functional group [38]. Furthermore, the HRP-initiated gen-
eration of free radicals captured by a cell might be a ge-
neric means for detecting the reaction products of other
enzymes that unmask a pro-substrate, which then serves
as a substrate for HRP [6].
SIGNIFICANCE
To our knowledge, we present the first application of
yeast surface display to in vitro selection of altered en-
zymatic activity. The method immobilizes one of the
reaction substrates, as well as a library of enzyme var-
iants, on the surface of live yeast cells. A second, fluo-
rescent substrate is then supplied in solution and is
utilized by the active enzyme variants to label those
cells that express such active variants. Labeled yeast
cells are subsequently captured by fluorescence-acti-
vated sorting. The use of a eukaryotic organism to dis-
play the enzyme under selectionmakes possible the in185, October 2007 ª2007 Elsevier Ltd All rights reserved 1181
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Selection for Enantioselectivity for D- over L-Tyrosinol
Clone Mutations Freq. ED/L
WT HRP 0.9 ± 0.1
ED8.05 S73L 19% 0.8 ± 0.1
WT HRP 14% 0.9 ± 0.1
ED8.02 G69A, S126G, A134T, P146S 14% 0.9 ± 0.1
ED8.01 L215R, T257S, N268S 5% ND
ED8.04 N9S, I22L 5% ND
ED8.06 S216N 5% ND
ED8.07 P261A 5% ND
ED8.08 E249G 5% ND
ED8.10 R93G 5% ND
ED8.11 F221L 5% ND
ED8.16 N214S, N307D 5% ND
ED8.17 S73T 5% ND
ED8.18 S126G 5% ND
Selection for Enantioselectivity for L- over D-Tyrosinol
Clone Sequence Freq. EL/D
WT HRP 1.2 ± 0.1
WT HRP 74% 1.2 ± 0.1
EL8.02 I32V, G213D 17% 1.2 ± 0.04
EL8.08 S216G 4% ND
EL8.22 V235M 4% ND
HRP variants from the randomly mutagenized library, HRP-E, were selected for enantioselectivity for D-tyrosinol (ED/L) or L-tyrosinol
(EL/D). Mutations from the wild-type HRP sequence are shown. ND, not determined. Errors were derived from two independent
experiments.vitro evolution of a number of enzymes that cannot be
expressed in a soluble and active form in bacteria,
such as highly disulfide-crosslinked enzymes.
We used a combination of positive and negative
selections to identify variants of HRP that are enantio-
selective for D- or L-tyrosinol, and we succeeded at
enhancing and even reversing the enantioselectivity
from that of the slight preference for L-tyrosinol shown
by wild-type HRP to a substantial preference for D-ty-
rosinol, a 4-fold change in enantioselectivity. In a sep-
arate selection, we improved the enantioselectivity forL-tyrosinol compared to wild-type HRP 8-fold. A com-
parison of selections from two different HRP-based
libraries revealed that an active-site-directed library
yielded variants with a large change in enantioselec-
tivity, whereas a randomly mutagenized library failed
to yield improved clones; this difference could be
due to the superior sampling of multiple mutations in
the vicinity of the active site by the active-site-directed
library.
The immobilized substrate used in our selectionwas
tyrosine, present naturally in proteins associated withFigure 5. Enantioselectivities of Wild-
Type and Variant HRP
(A and B) Enantioselectivities of wild-type HRP
and variants selected for specificity for (A)
D- over L-tyrosinol and (B) L- over D-tyrosinol.
Errors were derived from two independent
experiments.
1182 Chemistry & Biology 14, 1176–1185, October 2007 ª2007 Elsevier Ltd All rights reserved
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derivatizing the yeast surface with a variety of small
molecules, the scope of enzyme yeast surface display
can be extended by using any nontoxic substrate that
can be conjugated to a standard linker.
EXPERIMENTAL PROCEDURES
Synthesis and Cloning of the Wild-Type HRP Gene
The gene for wild-type HRP, redesigned to introduce a number of
unique restriction sites without altering the protein sequence (Fig-
ure 1B), was synthesized by GenScript (Piscataway, NJ). A new yeast
surface display vector, pCTcon2, was derived from plasmid pCTcon
[10] by replacing the DNA encoding the (Gly-Gly-Gly-Ser)3 linker with
a less repetitive DNA sequence (50-GGTGGAGGAGGCTCTGGTGGAG
GCGGTAGCGGAGGCGGAGGGTCG-30 ), again without mutating the
encoded peptide-linker sequence. The synthetic HRP gene and the
pCTcon2 plasmid were digested with NheI and BamHI, and the HRP
gene was ligated into the BamHI-NheI backbone of pCTcon2. The
resulting plasmid, pCT2-HRP, was transformed into the yeast surface
display strain of S. cerevisiae, EBY100 [10].
Construction of the HRP-Based Library, HRP-E, by Using
Error-Prone PCR
Library HRP-E was made by amplifying the HRP insert in pCT2-HRP
in the presence of nucleotide analogs as described previously [10].
Cotransformation of EBY100 with the BamHI-EcoRI backbone of
pCT2con and the amplified, mutated HRP gene by following the pub-
lishedmethod [10] yielded a library of 1.63 106 clones in EBY100. DNA
sequencing of 24 library clones revealed 0–17 mutations per clone (at
the nucleotide level), with a median of 3 mutations per clone. Two of
the 24 sequenced clones had the wild-type HRP gene sequence.
Selection of the Five Active-Site Positions for Randomization
Groups of 5 residue positions were chosen based on structural prox-
imity to the active site, and computational protein design techniques
(the dead-end elimination [39] and A* algorithms [40]) were used to de-
termine allowed sequences for the wild-type backbone structure
within 15 kcal/mol of the wild-type energy, which corresponds to the
free energy of unfolding of an extremely stable protein [41]. The pair-
wise energy function for these calculations was the sum of the van
der Waals, solvent-accessible surface area [42] and a Coulombic elec-
trostatic term with a dielectric constant of four times the distance be-
tween each pair of atoms [43]. These calculations highlighted multiple
sets of candidate positions that were calculated to allow many se-
quences. Further analysis of the built structures shows that they did
not fill the active site with heavy atoms or consist of many charged res-
Table 3. Properties of Single-Site Revertants of Variant
CD8.02
Clone Sequence ED/L
WT HRP FGNANSA 0.9 ± 0.1
CD8.02 EP..KA. 3.4 ± 0.2
Rev68 .P..KA. 1.7 ± 0.1
Rev69 E...KA. NA
Rev72 EP...A. NA
Rev73 EP..K.. 5.5 ± 0.4
ED/L, enantioselectivity for D-tyrosinol; NA, not active (less than
10% of wild-type HRP activity). The residues randomized to
generate library HRP-C are underlined. Errors were derived
from two independent experiments.Chemistry & Biology 14, 1176–11idues. We then used three other metrics to choose the positions for
randomization: mutual information between positions in our sequence
alignments, amino acid frequency in known genes, and ease of synthe-
sis. Mutual information was used to seek interactive positions, which
are of special interest. The mutual information [44] between positions
highlights pairs that might be structurally dependent on each other
and therefore might be forced to mutate in unison. A sequence align-
ment of HRP genes was taken from Pfam [45], and our wild-type
HRP gene sequence was aligned by eye with the most highly homolo-
gous of the 309 seed alignment sequences to create a sequence align-
ment of 310 sequences. Highly conserved positions in this alignment
were considered to be risky for randomization. We chose to mutate
Phe68, Gly69, Asn72, Ser73, and Ala74, which the computational
protein design techniques indicated would allow mutation. These
5 residues had low conservation in our sequence alignment and
moderate mutual information; in addition, their close proximity in
sequence made them easy to modify with a single randomized oligo-
nucleotide.
Construction of the HRP-Based Library, HRP-C, Using Active-
Site-Directed Saturation Mutagenesis
Library HRP-C was constructed by replacing the BstBI-EagI fragment
of the wild-type HRP gene (Figure 1B) with a synthetic DNA fragment
randomized at amino acid positions 68, 69, 72, 73, and 74. The syn-
thetic DNA fragment was assembled from two defined oligonucleo-
tides, c1 (50-GTTGTGACGCATCGATCTTGTTAGACAACACAACATCA
TTTCGAACAGAGAAAGATGCG-30) and c2 (50-CTGCGCAGGATACA
GTTCTTGGGCATGCACTCTCCACGGCCGCCTTCATTCTGTCAATCA
CAG-30GAAATCCGC), and one randomized oligonucleotide, rC (50-CA
TCATTTCGAACAGAGAAAGATGCG11AACGCA111CGCGGATTTCCT
GTGATTGACAGAATG-30), where ‘‘1’’ stands for an equimolar mixture
of codons encoding for the 19 non-cysteine amino acid residues. The
triphosphoramidite codon mixture was purchased from Glen Research
(Sterling, VA), and the randomized oligonucleotide was synthesized
manually by Trilink (San Diego, CA).
The oligonucleotides were assembled by using KOD Hot Start Poly-
merase (Novagen, San Diego, CA). First, 20 pmol oligonuclotide c2 and
10 pmol oligonuclotide rCwere combinedwith 1UKODHot Start Poly-
merase in 50 ml KOD Mix (1 3 KOD buffer, 0.2 mM dNTP mix, 1 mM
MgSO4, 1 M betaine, and 3% DMSO). The oligonucleotides were
denatured for 2 min at 95C; subjected to ten cycles of 30 s at 94C,
30 s at 58C, and 1 min at 68C; and, finally, incubated for 10 min at
68C. A total of 20 pmol of c1 was added to the mixture in 2 ml, and
the thermocycling program was repeated as described above. The re-
sulting double-stranded DNA fragment was ethanol precipitated, and
2 mg of the product was amplified 10-fold by limiting the amounts of
the PCR primers pc1 (50-GTTGTGACGCATCGATCTTGTTAGAC-30)
and pc2 (50-CTGCGCAGGATACAGTTCTTGGGC-30), and by using
20 cycles of the program described above with 30 U KOD Hot Start
Polymerase in 1.5 ml KOD mix. The amplified DNA fragment (‘‘HRP-
C insert’’) was again ethanol precipitated and resuspended in dH2O
at 0.6 mg/ml.
The pCT2-HRP plasmidmissing the BstBI-EagI fragment (Figure 1B)
was prepared by a sequence of restriction digests (EagI, BssHII, and
BstBI), followed by purification on QIAGEN PCR-Purification columns
and ethanol precipitation. The gapped pCT2-HRP plasmid and HRP-C
insert, which overlapped in sequence with the ends of the gapped
pCT2-HRP plasmid by 41 nucleotides both upstream of the BstBI re-
striction site and downstream of the EagI site, were cotransformed
into EBY100 by following the established protocol [10]. A total of 20
mg of gapped pCT2-HRP and 30 mg HRP-C insert were transformed
into 1 ml electro-competent EBY100, yielding a yeast surface display
library of an estimated 9.0 3 107 independent transformants, which
is larger than the 2.53 106 possible sequence permutations permitted
by library design. Of the 24 clones from library HRP-C that were se-
quenced, 22 conformed to the library design, and 2 showed protein
truncations due to frameshift mutations.85, October 2007 ª2007 Elsevier Ltd All rights reserved 1183
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Tyrosinol (Sigma-Aldrich, St. Louis, MO) dissolved in 50 mM sodium
borate buffer (pH 8.6) was added in 10-foldmolar excess to Alexa Fluor
488 succinimidyl ester (Molecular Probes/Invitrogen, Carlsbad, CA).
The mixture was stirred at room temperature for 3 hr. The fluorescently
labeled product was then purified by reverse-phase HPLC by using
a 9.4 3 250 mm, 5 mM Zorbax Rx-C8 column (Agilent Technologies,
Santa Clara, CA) with 0.1% TFA, by using water as loading buffer
and 0.1% TFA acetonitrile as mobile phase. The product was eluted
with a 30 min, 4 ml/min gradient of 10%–30% acetonitrile.
Labeling of HRP Libraries Displayed on the Yeast Surface
A yeast culture containing either 10 copies of each clone or 2 3 106
cells, whichever was the larger, was induced at the cell density of
4 3 105/ml by growing the culture in 90% SG-CAA, 10% SD-CAA,
3.6 mM d-aminolevulinic acid, and 0.2 mM ferric citrate for 18 hr at
30C. Twomillion induced yeast cells were washed with 1ml PBS con-
taining 0.5% BSA, followed by 0.5 ml PBS with 0.1% BSA. The cells
were resuspended in 200 ml PBS containing 0.003% H2O2 and
15 mM L- or D-tyrosinol-Alexa 488. Yeast populations for FACSwere in-
cubated for 30min at 30C, whereas samples used to determine enan-
tioselectivities of selected clones were incubated for 2–8 min at room
temperature. Labeling reactions were stopped by adding a 103 ex-
cess of PBS containing 0.5% BSA and 10 mM ascorbic acid and
were washed by 0.5 ml PBS with 0.1% BSA. Samples for FACS
were then labeled as described previously [10] with anti-c-mycmono-
clonal antibody, 9E10 (Covance, Princeton, NJ), and with goat anti-
mouse Alexa-PE polyclonal antibodies, and then were resuspended
in 0.5 ml PBS with 0.1% BSA.
Sorting of HRP Libraries Displayed on the Yeast Surface
Using Fluorescence-Activated Cell Sorting
Double-labeled yeast cells were sorted on a Becton Dickinson (Frank-
lin Lakes, NJ) Aria high-speed cell sorter with 488 nm and 635 nm
lasers at the rates of 6,000–10,000 cells per s. Gates were adjusted
to collect the yeast cells positive for Alexa 633 signal that also had
the highest Alexa 488 signal (for the positive selection rounds 1, 3, 5,
and 7) or the lowest Alexa 488 signal (for the negative selection rounds
2, 4, 6, and 8). Of the Alexa 633-positive cells, the 1% of the cells with
the highest Alexa 488 signal was collected in round 1, whereas 0.5% of
the cells with the highest Alexa 488 signal was collected in rounds 3, 5,
and 7. Conversely, of the Alexa 633-positive cells, 3% of the cells with
the highest Alexa 488 signal was excluded in round 2, and 10% of the
cells with the highest Alexa 488 signal was excluded in rounds 4, 6, and
8. Selected cells were collected in 0.5 ml SD-CAA (pH 4.5), containing
50 mg/ml kanamycin, 100 U/ml penicillin G, and 200 U/ml streptomy-
cin, then grown to saturation in 5 ml of the same media by shaking
them at 30C for 2 days before they were induced and labeled for
the next round of sorting.
Isolation of Selected HRP Variants
After eight rounds of selection, plasmid DNA was extracted from 1 ml
of each saturated culture by using the Zymoprep Yeast Plasmid
Miniprep Kit (Zymo Research, Orange, CA) and was transformed into
XL1-Blue-competent E. coli (Stratagene, La Jolla, CA). Plasmids
from 21–23 colonies from each selection were sequenced; those
encoding unique HRP variants were retransformed into EBY100 for
characterization of enantioselectivity.
Characterization of HRP Variants
To determine the enantioselectivities of selected HRP variants, yeast
cells transformed with each variant of interest were labeled in parallel
with L- and D-tyrosinol as described above for 0–4 min. Each time point
sample was analyzed by using a Coulter (Fullerton, CA) Epics XL flow
cytometer. The mean fluorescence of Alexa 488 was plotted against
time to determine the initial reaction rates with each substrate (Fig-
ure 4), and the enantioselectivity was calculated as ED/L = (initial rate1184 Chemistry & Biology 14, 1176–1185, October 2007 ª2007with D-tyrosinol)/(initial rate with L-tyrosinol) and EL/D = (initial rate with
L-tyrosinol)/(initial rate with D-tyrosinol). Clearly, ED/L 3 EL/D = 1.
Mutagenesis of Enantioselective Variant CD8.02
The four non-wild-type residues in variant CD8.02, Glu68, Pro69,
Lys72, and Ala73, were mutated back to wild-type HRP by using the
same strategy as in the construction of library HRP-C, except that
oligonucleotides with defined sequences were used instead of the
randomized oligonucleotide, rC. Mutant Rev68 (CD8.02 E68F) was
constructed by using oligonucleotide 50-CATCATTTCGAACAGAGAA
AGATGCGTTTCCTAACGCAAAGGCAGCGCGCGGATTTCCTGTGAT
TGACAGAATG-30; mutant Rev69 (CD8.02 P69G) was constructed by
using oligonucleotide 50-CATCATTTCGAACAGAGAAAGATGCGGAG
GGGAACGCAAAGGCAGCGCGCGGATTTCCTGTGATTGACAGAATG-
30; mutant Rev72 (CD8.02 K72N) was constructed by using oligonucle-
otide 50-CATCATTTCGAACAGAGAAAGATGCGGAGCCTAACGCAAA
CGCAGCGCGCGGATTTCCTGTGATTGACAGAATG-30; and mutant
Rev73 (CD8.02 A73S) was constructed by using oligonucleotide 50-CAT
CATTTCGAACAGAGAAAGATGCGGAGCCTAACGCAAAGTCGGCGCG
CGGATTTCCTGTGATTGACAGAATG-30.
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